date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.714570900039465.
The log-likelihood improved by 3.659.
Iteration 2 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 1.794.
Step length converged once. Increasing MCMC sample size.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.07705.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       2       13     1244     1049      810      360      369      344 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     265      236      128       86       42       29       11        8 
degree16 degree17 
       3        1 
1 
disease_progression 
H-positive risk:  866 903 111 858 440 123 881 425 136 78 124 55 
H-negative risk:  903 866 881 858 425 440 123 111 124 136 55 78 
New BC onsets:  1
BC status:  4999 1 
BC subtype:  4999 1 

clinical_engagement 
diagnosis 
demography 
60 new agents 
2 
disease_progression 
H-positive risk:  869 910 111 859 436 121 883 422 139 76 122 52 
H-negative risk:  910 869 883 859 422 436 121 111 122 139 52 76 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 1 2 

clinical_engagement 
diagnosis 
demography 
68 new agents 
3 
disease_progression 
H-positive risk:  867 917 111 859 432 122 882 422 139 73 123 53 
H-negative risk:  917 867 882 859 422 432 122 111 123 139 53 73 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 3 2 

clinical_engagement 
diagnosis 
demography 
67 new agents 
4 
disease_progression 
H-positive risk:  873 927 111 861 431 120 876 414 138 75 121 53 
H-negative risk:  927 873 876 861 414 431 120 111 121 138 53 75 
New BC onsets:  9
BC status:  4991 9 
BC subtype:  4991 7 2 

clinical_engagement 
diagnosis 
demography 
70 new agents 
5 
disease_progression 
H-positive risk:  885 934 113 856 429 121 873 406 138 73 122 50 
H-negative risk:  934 885 873 856 406 429 121 113 122 138 50 73 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 9 2 

clinical_engagement 
diagnosis 
demography 
68 new agents 
6 
disease_progression 
H-positive risk:  895 936 114 860 422 123 874 394 137 74 123 48 
H-negative risk:  936 895 874 860 394 422 123 114 123 137 48 74 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 10 3 

clinical_engagement 
diagnosis 
demography 
63 new agents 
7 
disease_progression 
H-positive risk:  893 944 115 856 418 123 874 394 139 76 123 45 
H-negative risk:  944 893 874 856 394 418 123 115 123 139 45 76 
New BC onsets:  15
BC status:  4985 15 
BC subtype:  4985 11 4 

clinical_engagement 
diagnosis 
demography 
55 new agents 
8 
disease_progression 
H-positive risk:  891 951 114 862 411 124 872 396 139 75 122 43 
H-negative risk:  951 891 872 862 396 411 124 114 122 139 43 75 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 12 4 

clinical_engagement 
diagnosis 
demography 
72 new agents 
9 
disease_progression 
H-positive risk:  894 964 115 860 403 128 865 388 141 75 124 43 
H-negative risk:  964 894 865 860 388 403 128 115 124 141 43 75 
New BC onsets:  19
BC status:  4981 19 
BC subtype:  4981 12 7 

clinical_engagement 
diagnosis 
demography 
51 new agents 
10 
disease_progression 
H-positive risk:  897 967 111 865 402 129 863 385 142 73 123 43 
H-negative risk:  967 897 863 865 385 402 129 111 123 142 43 73 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 13 7 

clinical_engagement 
diagnosis 
demography 
59 new agents 
11 
disease_progression 
H-positive risk:  903 970 111 856 397 131 871 386 140 71 123 41 
H-negative risk:  970 903 871 856 386 397 131 111 123 140 41 71 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 13 7 

clinical_engagement 
diagnosis 
demography 
74 new agents 
12 
disease_progression 
H-positive risk:  902 976 113 855 394 131 874 378 142 71 123 41 
H-negative risk:  976 902 874 855 378 394 131 113 123 142 41 71 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 14 10 

clinical_engagement 
diagnosis 
demography 
44 new agents 
13 
disease_progression 
H-positive risk:  839 895 104 936 393 119 945 373 154 71 129 42 
H-negative risk:  895 839 945 936 373 393 119 104 129 154 42 71 
New BC onsets:  25
BC status:  4975 25 
BC subtype:  4975 16 9 

clinical_engagement 
diagnosis 
demography 
213 new agents 
14 
disease_progression 
H-positive risk:  866 926 109 902 411 125 905 375 140 72 121 48 
H-negative risk:  926 866 905 902 375 411 125 109 121 140 48 72 
New BC onsets:  30
BC status:  4970 30 
BC subtype:  4970 21 9 

clinical_engagement 
diagnosis 
demography 
66 new agents 
15 
disease_progression 
H-positive risk:  871 934 111 899 411 127 896 367 142 71 123 48 
H-negative risk:  934 871 896 899 367 411 127 111 123 142 48 71 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 22 9 

clinical_engagement 
diagnosis 
demography 
74 new agents 
16 
disease_progression 
H-positive risk:  874 931 114 886 414 126 902 367 145 72 121 48 
H-negative risk:  931 874 902 886 367 414 126 114 121 145 48 72 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 23 9 

clinical_engagement 
diagnosis 
demography 
57 new agents 
17 
disease_progression 
H-positive risk:  880 934 112 883 410 129 906 363 143 73 121 46 
H-negative risk:  934 880 906 883 363 410 129 112 121 143 46 73 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 25 9 

clinical_engagement 
diagnosis 
demography 
56 new agents 
18 
disease_progression 
H-positive risk:  888 936 112 883 398 130 908 365 143 70 121 46 
H-negative risk:  936 888 908 883 365 398 130 112 121 143 46 70 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 24 9 

clinical_engagement 
diagnosis 
demography 
60 new agents 
19 
disease_progression 
H-positive risk:  899 945 113 876 397 130 904 358 144 69 120 45 
H-negative risk:  945 899 904 876 358 397 130 113 120 144 45 69 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 26 9 

clinical_engagement 
diagnosis 
demography 
58 new agents 
20 
disease_progression 
H-positive risk:  904 944 112 872 394 130 906 362 142 69 121 44 
H-negative risk:  944 904 906 872 362 394 130 112 121 142 44 69 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 29 10 

clinical_engagement 
diagnosis 
demography 
51 new agents 
21 
disease_progression 
H-positive risk:  901 945 115 874 395 128 906 360 142 68 122 44 
H-negative risk:  945 901 906 874 360 395 128 115 122 142 44 68 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 29 10 

clinical_engagement 
diagnosis 
demography 
51 new agents 
22 
disease_progression 
H-positive risk:  907 949 115 875 391 130 905 357 139 68 120 44 
H-negative risk:  949 907 905 875 357 391 130 115 120 139 44 68 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 29 10 

clinical_engagement 
diagnosis 
demography 
68 new agents 
23 
disease_progression 
H-positive risk:  911 955 117 870 387 133 907 350 140 70 118 42 
H-negative risk:  955 911 907 870 350 387 133 117 118 140 42 70 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 30 11 

clinical_engagement 
diagnosis 
demography 
57 new agents 
24 
disease_progression 
H-positive risk:  916 956 119 868 383 136 896 359 138 69 118 42 
H-negative risk:  956 916 896 868 359 383 136 119 118 138 42 69 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 31 11 

clinical_engagement 
diagnosis 
demography 
74 new agents 
25 
disease_progression 
H-positive risk:  842 890 116 935 372 128 976 366 141 67 124 43 
H-negative risk:  890 842 976 935 366 372 128 116 124 141 43 67 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 33 11 

clinical_engagement 
diagnosis 
demography 
181 new agents 
26 
disease_progression 
H-positive risk:  868 905 117 899 395 130 944 378 135 61 122 46 
H-negative risk:  905 868 944 899 378 395 130 117 122 135 46 61 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 32 12 

clinical_engagement 
diagnosis 
demography 
70 new agents 
27 
disease_progression 
H-positive risk:  869 906 118 892 396 132 939 384 136 61 123 44 
H-negative risk:  906 869 939 892 384 396 132 118 123 136 44 61 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 36 11 

clinical_engagement 
diagnosis 
demography 
55 new agents 
28 
disease_progression 
H-positive risk:  865 914 118 897 392 130 941 379 137 60 123 44 
H-negative risk:  914 865 941 897 379 392 130 118 123 137 44 60 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 36 12 

clinical_engagement 
diagnosis 
demography 
74 new agents 
29 
disease_progression 
H-positive risk:  867 918 120 894 387 130 934 383 140 61 122 44 
H-negative risk:  918 867 934 894 383 387 130 120 122 140 44 61 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 39 12 

clinical_engagement 
diagnosis 
demography 
67 new agents 
30 
disease_progression 
H-positive risk:  871 920 119 892 383 131 941 375 139 61 122 46 
H-negative risk:  920 871 941 892 375 383 131 119 122 139 46 61 
New BC onsets:  54
BC status:  4946 54 
BC subtype:  4946 42 12 

clinical_engagement 
diagnosis 
demography 
61 new agents 
31 
disease_progression 
H-positive risk:  876 923 116 892 385 133 945 366 138 60 121 45 
H-negative risk:  923 876 945 892 366 385 133 116 121 138 45 60 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 41 12 

clinical_engagement 
diagnosis 
demography 
54 new agents 
32 
disease_progression 
H-positive risk:  880 920 115 893 382 133 944 368 136 61 121 47 
H-negative risk:  920 880 944 893 368 382 133 115 121 136 47 61 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 43 12 

clinical_engagement 
diagnosis 
demography 
63 new agents 
33 
disease_progression 
H-positive risk:  887 921 118 891 376 133 945 363 133 62 123 48 
H-negative risk:  921 887 945 891 363 376 133 118 123 133 48 62 
New BC onsets:  59
BC status:  4941 59 
BC subtype:  4941 44 15 

clinical_engagement 
diagnosis 
demography 
61 new agents 
34 
disease_progression 
H-positive risk:  893 926 121 894 366 132 940 362 133 62 123 48 
H-negative risk:  926 893 940 894 362 366 132 121 123 133 48 62 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 47 17 

clinical_engagement 
diagnosis 
demography 
57 new agents 
35 
disease_progression 
H-positive risk:  898 925 123 893 368 130 946 355 131 61 123 47 
H-negative risk:  925 898 946 893 355 368 130 123 123 131 47 61 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 51 17 

clinical_engagement 
diagnosis 
demography 
61 new agents 
36 
disease_progression 
H-positive risk:  905 924 123 895 361 132 949 348 133 58 124 48 
H-negative risk:  924 905 949 895 348 361 132 123 124 133 48 58 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 50 17 

clinical_engagement 
diagnosis 
demography 
55 new agents 
37 
disease_progression 
H-positive risk:  845 851 118 965 357 117 1007 350 148 58 136 48 
H-negative risk:  851 845 1007 965 350 357 117 118 136 148 48 58 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 51 18 

clinical_engagement 
diagnosis 
demography 
152 new agents 
38 
disease_progression 
H-positive risk:  858 864 122 933 366 125 972 382 146 55 132 45 
H-negative risk:  864 858 972 933 382 366 125 122 132 146 45 55 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 53 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
39 
disease_progression 
H-positive risk:  862 869 122 937 356 124 961 388 149 55 133 44 
H-negative risk:  869 862 961 937 388 356 124 122 133 149 44 55 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 52 18 

clinical_engagement 
diagnosis 
demography 
66 new agents 
40 
disease_progression 
H-positive risk:  859 872 120 936 351 125 971 388 148 56 128 46 
H-negative risk:  872 859 971 936 388 351 125 120 128 148 46 56 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 53 18 

clinical_engagement 
diagnosis 
demography 
56 new agents 
41 
disease_progression 
H-positive risk:  862 873 122 930 358 125 970 384 146 53 130 47 
H-negative risk:  873 862 970 930 384 358 125 122 130 146 47 53 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 53 18 

clinical_engagement 
diagnosis 
demography 
59 new agents 
42 
disease_progression 
H-positive risk:  866 878 124 930 356 127 966 377 146 52 130 48 
H-negative risk:  878 866 966 930 377 356 127 124 130 146 48 52 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 54 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
43 
disease_progression 
H-positive risk:  869 883 124 922 356 126 961 380 147 53 127 52 
H-negative risk:  883 869 961 922 380 356 126 124 127 147 52 53 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 56 19 

clinical_engagement 
diagnosis 
demography 
56 new agents 
44 
disease_progression 
H-positive risk:  874 890 124 918 356 128 955 382 144 53 126 50 
H-negative risk:  890 874 955 918 382 356 128 124 126 144 50 53 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 58 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
45 
disease_progression 
H-positive risk:  873 891 124 919 359 128 956 375 143 54 127 51 
H-negative risk:  891 873 956 919 375 359 128 124 127 143 51 54 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 60 19 

clinical_engagement 
diagnosis 
demography 
47 new agents 
46 
disease_progression 
H-positive risk:  873 896 124 915 364 129 949 377 143 53 127 50 
H-negative risk:  896 873 949 915 377 364 129 124 127 143 50 53 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 60 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
47 
disease_progression 
H-positive risk:  875 899 126 917 364 127 949 374 143 54 123 49 
H-negative risk:  899 875 949 917 374 364 127 126 123 143 49 54 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 59 18 

clinical_engagement 
diagnosis 
demography 
62 new agents 
48 
disease_progression 
H-positive risk:  873 914 125 905 364 128 949 370 144 55 122 51 
H-negative risk:  914 873 949 905 370 364 128 125 122 144 51 55 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 61 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
49 
disease_progression 
H-positive risk:  805 848 113 979 359 121 1012 371 150 56 135 51 
H-negative risk:  848 805 1012 979 371 359 121 113 135 150 51 56 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 61 17 

clinical_engagement 
diagnosis 
demography 
138 new agents 
50 
disease_progression 
H-positive risk:  816 852 117 958 359 121 1007 380 148 62 129 51 
H-negative risk:  852 816 1007 958 380 359 121 117 129 148 51 62 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 60 17 

clinical_engagement 
diagnosis 
demography 
88 new agents 
51 
disease_progression 
H-positive risk:  826 854 118 956 362 120 999 379 142 63 132 49 
H-negative risk:  854 826 999 956 379 362 120 118 132 142 49 63 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 60 16 

clinical_engagement 
diagnosis 
demography 
61 new agents 
52 
disease_progression 
H-positive risk:  828 860 116 947 358 123 1001 383 139 62 134 49 
H-negative risk:  860 828 1001 947 383 358 123 116 134 139 49 62 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 58 16 

clinical_engagement 
diagnosis 
demography 
70 new agents 
53 
disease_progression 
H-positive risk:  835 862 118 947 358 122 990 384 138 62 135 49 
H-negative risk:  862 835 990 947 384 358 122 118 135 138 49 62 
New BC onsets:  73
BC status:  4927 73 
BC subtype:  4927 56 17 

clinical_engagement 
diagnosis 
demography 
64 new agents 
54 
disease_progression 
H-positive risk:  843 864 120 944 357 122 990 376 137 60 138 49 
H-negative risk:  864 843 990 944 376 357 122 120 138 137 49 60 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 56 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
55 
disease_progression 
H-positive risk:  839 869 122 950 358 125 987 367 134 58 140 51 
H-negative risk:  869 839 987 950 367 358 125 122 140 134 51 58 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 55 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
56 
disease_progression 
H-positive risk:  835 862 126 957 353 125 990 369 133 60 141 49 
H-negative risk:  862 835 990 957 369 353 125 126 141 133 49 60 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 56 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
57 
disease_progression 
H-positive risk:  839 863 125 961 348 127 997 356 130 59 145 50 
H-negative risk:  863 839 997 961 356 348 127 125 145 130 50 59 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 58 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
58 
disease_progression 
H-positive risk:  848 874 126 953 345 128 993 354 129 58 145 47 
H-negative risk:  874 848 993 953 354 345 128 126 145 129 47 58 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 57 19 

clinical_engagement 
diagnosis 
demography 
61 new agents 
59 
disease_progression 
H-positive risk:  847 870 126 955 340 129 1001 357 131 56 143 45 
H-negative risk:  870 847 1001 955 357 340 129 126 143 131 45 56 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 57 20 

clinical_engagement 
diagnosis 
demography 
54 new agents 
60 
disease_progression 
H-positive risk:  854 871 125 956 337 130 997 354 132 57 141 46 
H-negative risk:  871 854 997 956 354 337 130 125 141 132 46 57 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 58 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
61 
disease_progression 
H-positive risk:  799 828 119 1003 330 133 1051 350 139 55 146 47 
H-negative risk:  828 799 1051 1003 350 330 133 119 146 139 47 55 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 61 20 

clinical_engagement 
diagnosis 
demography 
103 new agents 
62 
disease_progression 
H-positive risk:  806 834 118 983 333 131 1026 377 135 65 139 53 
H-negative risk:  834 806 1026 983 377 333 131 118 139 135 53 65 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 62 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
63 
disease_progression 
H-positive risk:  809 832 119 983 338 132 1015 386 135 63 136 52 
H-negative risk:  832 809 1015 983 386 338 132 119 136 135 52 63 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 62 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
64 
disease_progression 
H-positive risk:  811 829 119 990 342 134 1021 379 128 61 136 50 
H-negative risk:  829 811 1021 990 379 342 134 119 136 128 50 61 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 66 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
65 
disease_progression 
H-positive risk:  813 825 117 996 340 134 1021 384 125 60 137 48 
H-negative risk:  825 813 1021 996 384 340 134 117 137 125 48 60 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 68 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
66 
disease_progression 
H-positive risk:  819 825 115 1002 340 133 1019 381 126 59 136 45 
H-negative risk:  825 819 1019 1002 381 340 133 115 136 126 45 59 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
61 new agents 
67 
disease_progression 
H-positive risk:  819 827 116 995 343 130 1021 380 127 60 136 46 
H-negative risk:  827 819 1021 995 380 343 130 116 136 127 46 60 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
68 
disease_progression 
H-positive risk:  821 826 115 991 346 130 1024 377 127 61 137 45 
H-negative risk:  826 821 1024 991 377 346 130 115 137 127 45 61 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
69 
disease_progression 
H-positive risk:  824 827 116 1000 347 129 1020 370 129 61 132 45 
H-negative risk:  827 824 1020 1000 370 347 129 116 132 129 45 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
70 
disease_progression 
H-positive risk:  828 831 120 993 340 131 1022 373 127 60 131 44 
H-negative risk:  831 828 1022 993 373 340 131 120 131 127 44 60 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 71 26 

clinical_engagement 
diagnosis 
demography 
57 new agents 
71 
disease_progression 
H-positive risk:  834 833 121 995 337 130 1014 378 127 59 128 44 
H-negative risk:  833 834 1014 995 378 337 130 121 128 127 44 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
57 new agents 
72 
disease_progression 
H-positive risk:  834 841 122 995 337 127 1012 377 124 59 126 46 
H-negative risk:  841 834 1012 995 377 337 127 122 126 124 46 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 71 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
73 
disease_progression 
H-positive risk:  798 779 115 1057 343 118 1053 370 130 56 133 48 
H-negative risk:  779 798 1053 1057 370 343 118 115 133 130 48 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 69 29 

clinical_engagement 
diagnosis 
demography 
101 new agents 
74 
disease_progression 
H-positive risk:  797 781 118 1047 355 118 1035 380 136 54 128 51 
H-negative risk:  781 797 1035 1047 380 355 118 118 128 136 51 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 68 30 

clinical_engagement 
diagnosis 
demography 
80 new agents 
75 
disease_progression 
H-positive risk:  800 783 119 1041 354 114 1035 380 140 54 127 53 
H-negative risk:  783 800 1035 1041 380 354 114 119 127 140 53 54 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 67 28 

clinical_engagement 
diagnosis 
demography 
60 new agents 
76 
disease_progression 
H-positive risk:  801 784 122 1041 355 115 1032 381 138 52 126 53 
H-negative risk:  784 801 1032 1041 381 355 115 122 126 138 53 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
77 
disease_progression 
H-positive risk:  795 791 118 1040 357 114 1038 380 135 52 128 52 
H-negative risk:  791 795 1038 1040 380 357 114 118 128 135 52 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 71 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
78 
disease_progression 
H-positive risk:  800 787 118 1042 358 112 1041 376 138 49 127 52 
H-negative risk:  787 800 1041 1042 376 358 112 118 127 138 52 49 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 70 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
79 
disease_progression 
H-positive risk:  801 786 117 1048 353 112 1044 372 137 47 129 54 
H-negative risk:  786 801 1044 1048 372 353 112 117 129 137 54 47 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
80 
disease_progression 
H-positive risk:  795 783 116 1048 353 115 1046 382 135 45 125 57 
H-negative risk:  783 795 1046 1048 382 353 115 116 125 135 57 45 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
81 
disease_progression 
H-positive risk:  797 769 115 1052 350 119 1049 388 133 45 126 57 
H-negative risk:  769 797 1049 1052 388 350 119 115 126 133 57 45 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
82 
disease_progression 
H-positive risk:  791 768 118 1052 350 118 1055 387 134 45 125 57 
H-negative risk:  768 791 1055 1052 387 350 118 118 125 134 57 45 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
83 
disease_progression 
H-positive risk:  803 776 119 1042 347 120 1051 380 137 44 125 56 
H-negative risk:  776 803 1051 1042 380 347 120 119 125 137 56 44 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
84 
disease_progression 
H-positive risk:  809 777 121 1047 339 121 1046 379 140 45 123 53 
H-negative risk:  777 809 1046 1047 379 339 121 121 123 140 53 45 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
85 
disease_progression 
H-positive risk:  761 720 119 1100 335 114 1103 376 149 47 125 51 
H-negative risk:  720 761 1103 1100 376 335 114 119 125 149 51 47 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
111 new agents 
86 
disease_progression 
H-positive risk:  764 729 118 1082 348 112 1088 382 156 46 126 49 
H-negative risk:  729 764 1088 1082 382 348 112 118 126 156 49 46 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
87 
disease_progression 
H-positive risk:  758 728 119 1072 343 112 1100 389 155 47 129 48 
H-negative risk:  728 758 1100 1072 389 343 112 119 129 155 48 47 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
88 
disease_progression 
H-positive risk:  762 730 120 1065 351 109 1090 390 154 49 131 49 
H-negative risk:  730 762 1090 1065 390 351 109 120 131 154 49 49 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
64 new agents 
89 
disease_progression 
H-positive risk:  762 732 121 1065 352 105 1090 390 157 48 129 49 
H-negative risk:  732 762 1090 1065 390 352 105 121 129 157 49 48 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
90 
disease_progression 
H-positive risk:  756 734 118 1062 355 107 1096 391 156 48 131 46 
H-negative risk:  734 756 1096 1062 391 355 107 118 131 156 46 48 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
91 
disease_progression 
H-positive risk:  767 726 120 1066 354 106 1092 387 157 45 132 48 
H-negative risk:  726 767 1092 1066 387 354 106 120 132 157 48 45 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
92 
disease_progression 
H-positive risk:  770 732 119 1067 348 105 1090 389 158 46 130 46 
H-negative risk:  732 770 1090 1067 389 348 105 119 130 158 46 46 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
93 
disease_progression 
H-positive risk:  770 736 119 1076 338 105 1088 386 154 48 133 47 
H-negative risk:  736 770 1088 1076 386 338 105 119 133 154 47 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
64 new agents 
94 
disease_progression 
H-positive risk:  770 737 118 1082 334 104 1097 384 154 47 127 46 
H-negative risk:  737 770 1097 1082 384 334 104 118 127 154 46 47 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
57 new agents 
95 
disease_progression 
H-positive risk:  770 733 116 1079 333 104 1101 381 155 50 131 47 
H-negative risk:  733 770 1101 1079 381 333 104 116 131 155 47 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
47 new agents 
96 
disease_progression 
H-positive risk:  766 732 118 1080 329 104 1108 380 158 49 129 47 
H-negative risk:  732 766 1108 1080 380 329 104 118 129 158 47 49 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
97 
disease_progression 
H-positive risk:  732 690 108 1123 333 97 1141 378 165 48 137 48 
H-negative risk:  690 732 1141 1123 378 333 97 108 137 165 48 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
96 new agents 
98 
disease_progression 
H-positive risk:  733 692 106 1112 343 96 1125 393 170 48 130 52 
H-negative risk:  692 733 1125 1112 393 343 96 106 130 170 52 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
99 
disease_progression 
H-positive risk:  733 694 107 1107 349 97 1112 401 165 54 130 51 
H-negative risk:  694 733 1112 1107 401 349 97 107 130 165 51 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
100 
disease_progression 
H-positive risk:  738 696 106 1112 357 98 1106 394 158 56 126 53 
H-negative risk:  696 738 1106 1112 394 357 98 106 126 158 53 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
101 
disease_progression 
H-positive risk:  734 702 111 1107 357 96 1106 392 158 58 127 52 
H-negative risk:  702 734 1106 1107 392 357 96 111 127 158 52 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
64 new agents 
102 
disease_progression 
H-positive risk:  731 704 110 1116 350 95 1112 383 161 57 129 52 
H-negative risk:  704 731 1112 1116 383 350 95 110 129 161 52 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
103 
disease_progression 
H-positive risk:  735 712 112 1103 356 94 1113 383 159 56 127 50 
H-negative risk:  712 735 1113 1103 383 356 94 112 127 159 50 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
104 
disease_progression 
H-positive risk:  729 708 112 1106 358 94 1109 391 159 56 127 51 
H-negative risk:  708 729 1109 1106 391 358 94 112 127 159 51 56 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
105 
disease_progression 
H-positive risk:  731 701 112 1106 363 96 1113 385 157 57 129 50 
H-negative risk:  701 731 1113 1106 385 363 96 112 129 157 50 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
106 
disease_progression 
H-positive risk:  733 706 110 1099 357 95 1114 388 161 56 130 51 
H-negative risk:  706 733 1114 1099 388 357 95 110 130 161 51 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
107 
disease_progression 
H-positive risk:  737 705 114 1106 357 96 1110 382 159 55 128 51 
H-negative risk:  705 737 1110 1106 382 357 96 114 128 159 51 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
108 
disease_progression 
H-positive risk:  738 710 115 1110 353 97 1102 384 157 55 128 51 
H-negative risk:  710 738 1102 1110 384 353 97 115 128 157 51 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
109 
disease_progression 
H-positive risk:  688 680 105 1142 358 88 1150 385 162 55 139 48 
H-negative risk:  680 688 1150 1142 385 358 88 105 139 162 48 55 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
91 new agents 
110 
disease_progression 
H-positive risk:  694 669 105 1141 362 90 1139 392 160 53 140 55 
H-negative risk:  669 694 1139 1141 392 362 90 105 140 160 55 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
111 
disease_progression 
H-positive risk:  697 665 107 1148 364 91 1129 394 158 55 138 54 
H-negative risk:  665 697 1129 1148 394 364 91 107 138 158 54 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
112 
disease_progression 
H-positive risk:  703 663 107 1143 365 90 1128 395 159 52 141 54 
H-negative risk:  663 703 1128 1143 395 365 90 107 141 159 54 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
113 
disease_progression 
H-positive risk:  697 667 108 1148 356 88 1137 388 162 53 143 53 
H-negative risk:  667 697 1137 1148 388 356 88 108 143 162 53 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
114 
disease_progression 
H-positive risk:  701 663 108 1142 357 90 1138 391 163 52 144 51 
H-negative risk:  663 701 1138 1142 391 357 90 108 144 163 51 52 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
59 new agents 
115 
disease_progression 
H-positive risk:  700 661 112 1140 360 93 1133 395 161 52 138 55 
H-negative risk:  661 700 1133 1140 395 360 93 112 138 161 55 52 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
116 
disease_progression 
H-positive risk:  698 667 111 1139 359 94 1128 399 163 49 137 56 
H-negative risk:  667 698 1128 1139 399 359 94 111 137 163 56 49 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 79 27 

clinical_engagement 
diagnosis 
demography 
86 new agents 
117 
disease_progression 
H-positive risk:  705 665 116 1132 353 95 1132 395 165 48 137 57 
H-negative risk:  665 705 1132 1132 395 353 95 116 137 165 57 48 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 80 32 

clinical_engagement 
diagnosis 
demography 
65 new agents 
118 
disease_progression 
H-positive risk:  707 665 115 1140 355 96 1115 399 165 51 136 56 
H-negative risk:  665 707 1115 1140 399 355 96 115 136 165 56 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 78 31 

clinical_engagement 
diagnosis 
demography 
62 new agents 
119 
disease_progression 
H-positive risk:  706 666 116 1140 350 97 1115 401 166 50 136 57 
H-negative risk:  666 706 1115 1140 401 350 97 116 136 166 57 50 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 77 31 

clinical_engagement 
diagnosis 
demography 
88 new agents 
120 
disease_progression 
H-positive risk:  710 668 114 1137 356 96 1112 395 168 50 139 55 
H-negative risk:  668 710 1112 1137 395 356 96 114 139 168 55 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 78 31 

clinical_engagement 
diagnosis 
demography 
69 new agents 
121 
disease_progression 
H-positive risk:  656 612 114 1187 359 92 1161 404 167 51 142 55 
H-negative risk:  612 656 1161 1187 404 359 92 114 142 167 55 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 78 30 

clinical_engagement 
diagnosis 
demography 
97 new agents 
122 
disease_progression 
H-positive risk:  651 608 112 1176 373 97 1156 414 163 50 144 56 
H-negative risk:  608 651 1156 1176 414 373 97 112 144 163 56 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 78 31 

clinical_engagement 
diagnosis 
demography 
81 new agents 
123 
disease_progression 
H-positive risk:  649 604 112 1181 374 98 1163 408 161 50 146 54 
H-negative risk:  604 649 1163 1181 408 374 98 112 146 161 54 50 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 78 34 

clinical_engagement 
diagnosis 
demography 
78 new agents 
124 
disease_progression 
H-positive risk:  648 608 112 1179 369 99 1163 408 164 51 144 55 
H-negative risk:  608 648 1163 1179 408 369 99 112 144 164 55 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 76 34 

clinical_engagement 
diagnosis 
demography 
74 new agents 
125 
disease_progression 
H-positive risk:  657 611 111 1173 379 101 1153 406 161 50 142 56 
H-negative risk:  611 657 1153 1173 406 379 101 111 142 161 56 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 77 34 

clinical_engagement 
diagnosis 
demography 
88 new agents 
126 
disease_progression 
H-positive risk:  663 617 112 1172 367 99 1156 404 156 50 146 58 
H-negative risk:  617 663 1156 1172 404 367 99 112 146 156 58 50 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 80 33 

clinical_engagement 
diagnosis 
demography 
80 new agents 
127 
disease_progression 
H-positive risk:  661 617 110 1173 370 97 1155 401 159 48 150 59 
H-negative risk:  617 661 1155 1173 401 370 97 110 150 159 59 48 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 79 35 

clinical_engagement 
diagnosis 
demography 
66 new agents 
128 
disease_progression 
H-positive risk:  659 623 107 1170 379 95 1152 401 159 49 152 54 
H-negative risk:  623 659 1152 1170 401 379 95 107 152 159 54 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 79 33 

clinical_engagement 
diagnosis 
demography 
62 new agents 
129 
disease_progression 
H-positive risk:  662 624 106 1163 374 96 1161 402 160 45 153 54 
H-negative risk:  624 662 1161 1163 402 374 96 106 153 160 54 45 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 81 33 

clinical_engagement 
diagnosis 
demography 
76 new agents 
130 
disease_progression 
H-positive risk:  659 636 107 1155 372 96 1154 405 159 45 157 55 
H-negative risk:  636 659 1154 1155 405 372 96 107 157 159 55 45 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 78 32 

clinical_engagement 
diagnosis 
demography 
91 new agents 
131 
disease_progression 
H-positive risk:  668 641 107 1157 373 96 1145 392 160 48 160 53 
H-negative risk:  641 668 1145 1157 392 373 96 107 160 160 53 48 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 76 33 

clinical_engagement 
diagnosis 
demography 
59 new agents 
132 
disease_progression 
H-positive risk:  663 643 109 1155 376 97 1147 395 157 49 159 50 
H-negative risk:  643 663 1147 1155 395 376 97 109 159 157 50 49 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 75 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
133 
disease_progression 
H-positive risk:  659 650 112 1158 374 100 1138 396 158 48 157 50 
H-negative risk:  650 659 1138 1158 396 374 100 112 157 158 50 48 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
90 new agents 
134 
disease_progression 
H-positive risk:  659 645 114 1146 376 100 1144 400 153 53 160 50 
H-negative risk:  645 659 1144 1146 400 376 100 114 160 153 50 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 69 34 

clinical_engagement 
diagnosis 
demography 
82 new agents 
135 
disease_progression 
H-positive risk:  663 641 117 1148 376 100 1135 402 155 51 163 49 
H-negative risk:  641 663 1135 1148 402 376 100 117 163 155 49 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 72 35 

clinical_engagement 
diagnosis 
demography 
92 new agents 
136 
disease_progression 
H-positive risk:  668 639 116 1149 377 97 1143 390 159 49 164 49 
H-negative risk:  639 668 1143 1149 390 377 97 116 164 159 49 49 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 72 36 

clinical_engagement 
diagnosis 
demography 
78 new agents 
137 
disease_progression 
H-positive risk:  674 642 115 1142 379 97 1141 387 160 48 162 53 
H-negative risk:  642 674 1141 1142 387 379 97 115 162 160 53 48 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 72 36 

clinical_engagement 
diagnosis 
demography 
81 new agents 
138 
disease_progression 
H-positive risk:  662 645 114 1148 381 95 1145 384 163 50 161 52 
H-negative risk:  645 662 1145 1148 384 381 95 114 161 163 52 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 75 34 

clinical_engagement 
diagnosis 
demography 
82 new agents 
139 
disease_progression 
H-positive risk:  653 644 117 1143 382 102 1146 390 161 51 158 53 
H-negative risk:  644 653 1146 1143 390 382 102 117 158 161 53 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 74 34 

clinical_engagement 
diagnosis 
demography 
83 new agents 
140 
disease_progression 
H-positive risk:  660 638 116 1157 385 101 1143 385 157 49 154 55 
H-negative risk:  638 660 1143 1157 385 385 101 116 154 157 55 49 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 73 34 

clinical_engagement 
diagnosis 
demography 
72 new agents 
141 
disease_progression 
H-positive risk:  670 639 114 1161 384 100 1134 384 154 50 154 56 
H-negative risk:  639 670 1134 1161 384 384 100 114 154 154 56 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 73 33 

clinical_engagement 
diagnosis 
demography 
76 new agents 
142 
disease_progression 
H-positive risk:  664 636 115 1153 384 101 1145 388 156 48 155 55 
H-negative risk:  636 664 1145 1153 388 384 101 115 155 156 55 48 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 74 32 

clinical_engagement 
diagnosis 
demography 
70 new agents 
143 
disease_progression 
H-positive risk:  663 635 113 1152 388 101 1150 385 154 45 157 57 
H-negative risk:  635 663 1150 1152 385 388 101 113 157 154 57 45 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
64 new agents 
144 
disease_progression 
H-positive risk:  659 633 111 1154 384 103 1152 386 157 45 159 57 
H-negative risk:  633 659 1152 1154 386 384 103 111 159 157 57 45 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 72 31 

clinical_engagement 
diagnosis 
demography 
71 new agents 
145 
disease_progression 
H-positive risk:  661 638 109 1154 391 104 1142 383 157 45 158 58 
H-negative risk:  638 661 1142 1154 383 391 104 109 158 157 58 45 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 70 32 

clinical_engagement 
diagnosis 
demography 
76 new agents 
146 
disease_progression 
H-positive risk:  643 637 110 1140 398 109 1146 396 156 46 160 59 
H-negative risk:  637 643 1146 1140 396 398 109 110 160 156 59 46 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 72 32 

clinical_engagement 
diagnosis 
demography 
88 new agents 
147 
disease_progression 
H-positive risk:  644 637 107 1138 405 109 1148 391 156 47 164 54 
H-negative risk:  637 644 1148 1138 391 405 109 107 164 156 54 47 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 70 30 

clinical_engagement 
diagnosis 
demography 
59 new agents 
148 
disease_progression 
H-positive risk:  642 639 109 1136 409 110 1153 377 156 47 168 54 
H-negative risk:  639 642 1153 1136 377 409 110 109 168 156 54 47 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 72 33 

clinical_engagement 
diagnosis 
demography 
73 new agents 
149 
disease_progression 
H-positive risk:  644 643 112 1128 414 107 1148 377 157 49 171 50 
H-negative risk:  643 644 1148 1128 377 414 107 112 171 157 50 49 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 73 33 

clinical_engagement 
diagnosis 
demography 
74 new agents 
150 
disease_progression 
H-positive risk:  647 643 113 1123 413 110 1143 386 155 48 168 51 
H-negative risk:  643 647 1143 1123 386 413 110 113 168 155 51 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 77 33 

clinical_engagement 
diagnosis 
demography 
75 new agents 
151 
disease_progression 
H-positive risk:  647 648 115 1122 414 108 1146 381 156 48 165 50 
H-negative risk:  648 647 1146 1122 381 414 108 115 165 156 50 48 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 81 33 

clinical_engagement 
diagnosis 
demography 
67 new agents 
152 
disease_progression 
H-positive risk:  651 652 117 1113 414 107 1145 380 156 47 166 52 
H-negative risk:  652 651 1145 1113 380 414 107 117 166 156 52 47 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 81 33 

clinical_engagement 
diagnosis 
demography 
78 new agents 
153 
disease_progression 
H-positive risk:  656 644 122 1119 416 105 1144 379 156 42 165 52 
H-negative risk:  644 656 1144 1119 379 416 105 122 165 156 52 42 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 85 32 

clinical_engagement 
diagnosis 
demography 
65 new agents 
154 
disease_progression 
H-positive risk:  657 650 125 1123 419 102 1141 373 154 43 162 51 
H-negative risk:  650 657 1141 1123 373 419 102 125 162 154 51 43 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 85 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
155 
disease_progression 
H-positive risk:  658 648 122 1132 418 102 1136 377 152 44 160 51 
H-negative risk:  648 658 1136 1132 377 418 102 122 160 152 51 44 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 84 30 

clinical_engagement 
diagnosis 
demography 
65 new agents 
156 
disease_progression 
H-positive risk:  654 635 119 1129 417 103 1140 389 153 46 161 54 
H-negative risk:  635 654 1140 1129 389 417 103 119 161 153 54 46 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 88 29 

clinical_engagement 
diagnosis 
demography 
70 new agents 
157 
disease_progression 
H-positive risk:  654 634 120 1120 414 105 1146 391 152 49 160 55 
H-negative risk:  634 654 1146 1120 391 414 105 120 160 152 55 49 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 90 30 

clinical_engagement 
diagnosis 
demography 
107 new agents 
158 
disease_progression 
H-positive risk:  652 636 118 1112 421 104 1150 393 151 50 158 55 
H-negative risk:  636 652 1150 1112 393 421 104 118 158 151 55 50 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 89 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
159 
disease_progression 
H-positive risk:  647 647 119 1105 422 102 1148 393 153 49 162 53 
H-negative risk:  647 647 1148 1105 393 422 102 119 162 153 53 49 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
66 new agents 
160 
disease_progression 
H-positive risk:  647 649 118 1101 421 100 1146 402 154 52 158 52 
H-negative risk:  649 647 1146 1101 402 421 100 118 158 154 52 52 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
161 
disease_progression 
H-positive risk:  642 652 116 1094 427 101 1149 399 153 54 160 53 
H-negative risk:  652 642 1149 1094 399 427 101 116 160 153 53 54 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
162 
disease_progression 
H-positive risk:  637 653 115 1099 428 97 1141 406 158 54 159 53 
H-negative risk:  653 637 1141 1099 406 428 97 115 159 158 53 54 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
163 
disease_progression 
H-positive risk:  636 651 113 1093 427 96 1142 411 161 56 160 54 
H-negative risk:  651 636 1142 1093 411 427 96 113 160 161 54 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
164 
disease_progression 
H-positive risk:  637 661 112 1096 425 95 1133 411 158 56 163 53 
H-negative risk:  661 637 1133 1096 411 425 95 112 163 158 53 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
165 
disease_progression 
H-positive risk:  644 665 112 1081 424 92 1131 418 161 57 163 52 
H-negative risk:  665 644 1131 1081 418 424 92 112 163 161 52 57 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
92 new agents 
166 
disease_progression 
H-positive risk:  657 655 113 1077 424 92 1125 423 159 58 164 53 
H-negative risk:  655 657 1125 1077 423 424 92 113 164 159 53 58 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
167 
disease_progression 
H-positive risk:  661 655 112 1080 423 90 1117 425 163 56 164 54 
H-negative risk:  655 661 1117 1080 425 423 90 112 164 163 54 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
87 new agents 
168 
disease_progression 
H-positive risk:  664 656 111 1087 415 93 1125 417 159 55 165 53 
H-negative risk:  656 664 1125 1087 417 415 93 111 165 159 53 55 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
169 
disease_progression 
H-positive risk:  668 664 114 1079 416 93 1116 421 156 58 163 52 
H-negative risk:  664 668 1116 1079 421 416 93 114 163 156 52 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
170 
disease_progression 
H-positive risk:  669 657 113 1075 430 96 1102 426 157 61 165 49 
H-negative risk:  657 669 1102 1075 426 430 96 113 165 157 49 61 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
171 
disease_progression 
H-positive risk:  669 654 111 1088 431 96 1093 426 154 64 163 51 
H-negative risk:  654 669 1093 1088 426 431 96 111 163 154 51 64 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
172 
disease_progression 
H-positive risk:  670 655 111 1093 426 92 1097 425 151 66 162 52 
H-negative risk:  655 670 1097 1093 425 426 92 111 162 151 52 66 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
173 
disease_progression 
H-positive risk:  667 654 114 1097 428 95 1094 418 153 64 164 52 
H-negative risk:  654 667 1094 1097 418 428 95 114 164 153 52 64 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
174 
disease_progression 
H-positive risk:  671 650 115 1095 432 94 1096 419 153 61 164 50 
H-negative risk:  650 671 1096 1095 419 432 94 115 164 153 50 61 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
175 
disease_progression 
H-positive risk:  675 649 119 1102 426 94 1091 419 149 63 162 51 
H-negative risk:  649 675 1091 1102 419 426 94 119 162 149 51 63 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
176 
disease_progression 
H-positive risk:  676 644 122 1103 431 94 1092 409 150 63 166 50 
H-negative risk:  644 676 1092 1103 409 431 94 122 166 150 50 63 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
93 new agents 
177 
disease_progression 
H-positive risk:  676 653 117 1095 432 94 1086 414 154 61 168 50 
H-negative risk:  653 676 1086 1095 414 432 94 117 168 154 50 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
178 
disease_progression 
H-positive risk:  675 656 113 1090 431 97 1087 422 154 61 166 48 
H-negative risk:  656 675 1087 1090 422 431 97 113 166 154 48 61 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 97 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
179 
disease_progression 
H-positive risk:  677 653 112 1102 428 96 1088 417 156 59 163 49 
H-negative risk:  653 677 1088 1102 417 428 96 112 163 156 49 59 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 99 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
180 
disease_progression 
H-positive risk:  680 656 111 1090 433 96 1084 417 158 61 167 47 
H-negative risk:  656 680 1084 1090 417 433 96 111 167 158 47 61 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 100 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
181 
disease_progression 
H-positive risk:  673 659 111 1081 435 92 1102 413 161 57 170 46 
H-negative risk:  659 673 1102 1081 413 435 92 111 170 161 46 57 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 101 20 

clinical_engagement 
diagnosis 
demography 
96 new agents 
182 
disease_progression 
H-positive risk:  674 665 112 1078 438 94 1092 416 164 53 168 46 
H-negative risk:  665 674 1092 1078 416 438 94 112 168 164 46 53 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 96 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
183 
disease_progression 
H-positive risk:  675 656 108 1087 438 94 1084 426 161 56 169 46 
H-negative risk:  656 675 1084 1087 426 438 94 108 169 161 46 56 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 98 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
184 
disease_progression 
H-positive risk:  677 660 108 1089 434 94 1082 424 156 58 172 46 
H-negative risk:  660 677 1082 1089 424 434 94 108 172 156 46 58 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 95 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
185 
disease_progression 
H-positive risk:  682 661 110 1100 428 93 1080 419 157 57 169 44 
H-negative risk:  661 682 1080 1100 419 428 93 110 169 157 44 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 94 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
186 
disease_progression 
H-positive risk:  688 663 110 1097 429 93 1086 417 153 57 164 43 
H-negative risk:  663 688 1086 1097 417 429 93 110 164 153 43 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
187 
disease_progression 
H-positive risk:  690 662 106 1095 429 97 1088 414 151 56 169 43 
H-negative risk:  662 690 1088 1095 414 429 97 106 169 151 43 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
188 
disease_progression 
H-positive risk:  696 659 108 1097 420 98 1085 414 151 59 168 45 
H-negative risk:  659 696 1085 1097 414 420 98 108 168 151 45 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
189 
disease_progression 
H-positive risk:  699 664 104 1078 425 95 1090 415 154 60 172 44 
H-negative risk:  664 699 1090 1078 415 425 95 104 172 154 44 60 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
190 
disease_progression 
H-positive risk:  704 666 103 1074 430 93 1086 412 154 59 173 46 
H-negative risk:  666 704 1086 1074 412 430 93 103 173 154 46 59 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 95 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
191 
disease_progression 
H-positive risk:  707 661 105 1080 428 95 1084 409 154 59 175 43 
H-negative risk:  661 707 1084 1080 409 428 95 105 175 154 43 59 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 98 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
192 
disease_progression 
H-positive risk:  712 657 101 1074 431 97 1091 405 156 58 176 42 
H-negative risk:  657 712 1091 1074 405 431 97 101 176 156 42 58 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 97 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
193 
disease_progression 
H-positive risk:  711 663 99 1083 418 96 1098 397 161 58 177 39 
H-negative risk:  663 711 1098 1083 397 418 96 99 177 161 39 58 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
194 
disease_progression 
H-positive risk:  712 664 95 1074 427 95 1094 406 161 58 174 40 
H-negative risk:  664 712 1094 1074 406 427 95 95 174 161 40 58 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 94 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
195 
disease_progression 
H-positive risk:  712 669 96 1072 425 96 1092 401 164 59 175 39 
H-negative risk:  669 712 1092 1072 401 425 96 96 175 164 39 59 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 98 25 

clinical_engagement 
diagnosis 
demography 
87 new agents 
196 
disease_progression 
H-positive risk:  715 671 95 1076 412 96 1095 405 164 57 171 43 
H-negative risk:  671 715 1095 1076 405 412 96 95 171 164 43 57 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 98 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
197 
disease_progression 
H-positive risk:  705 680 99 1084 402 94 1095 405 168 55 171 42 
H-negative risk:  680 705 1095 1084 405 402 94 99 171 168 42 55 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 99 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
198 
disease_progression 
H-positive risk:  708 679 96 1080 406 95 1081 412 168 56 175 44 
H-negative risk:  679 708 1081 1080 412 406 95 96 175 168 44 56 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 98 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
199 
disease_progression 
H-positive risk:  702 674 99 1092 402 95 1077 411 171 57 176 44 
H-negative risk:  674 702 1077 1092 411 402 95 99 176 171 44 57 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 100 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
200 
disease_progression 
H-positive risk:  700 672 100 1098 402 96 1073 412 169 58 176 44 
H-negative risk:  672 700 1073 1098 412 402 96 100 176 169 44 58 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 101 26 

clinical_engagement 
diagnosis 
demography 
64 new agents 
201 
disease_progression 
H-positive risk:  695 676 101 1098 400 96 1064 419 170 58 180 43 
H-negative risk:  676 695 1064 1098 419 400 96 101 180 170 43 58 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 105 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
202 
disease_progression 
H-positive risk:  698 670 99 1103 400 93 1061 415 172 61 180 48 
H-negative risk:  670 698 1061 1103 415 400 93 99 180 172 48 61 
New BC onsets:  131
BC status:  4869 131 
BC subtype:  4869 105 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
203 
disease_progression 
H-positive risk:  695 676 98 1094 404 92 1071 408 170 61 182 49 
H-negative risk:  676 695 1071 1094 408 404 92 98 182 170 49 61 
New BC onsets:  132
BC status:  4868 132 
BC subtype:  4868 106 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
204 
disease_progression 
H-positive risk:  691 677 97 1100 400 95 1073 405 169 59 185 49 
H-negative risk:  677 691 1073 1100 405 400 95 97 185 169 49 59 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 104 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
205 
disease_progression 
H-positive risk:  691 677 98 1082 412 98 1081 399 166 57 190 49 
H-negative risk:  677 691 1081 1082 399 412 98 98 190 166 49 57 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 102 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
206 
disease_progression 
H-positive risk:  697 682 98 1062 420 95 1074 412 166 57 185 52 
H-negative risk:  682 697 1074 1062 412 420 95 98 185 166 52 57 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 102 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
207 
disease_progression 
H-positive risk:  694 682 100 1065 418 97 1080 406 163 60 184 51 
H-negative risk:  682 694 1080 1065 406 418 97 100 184 163 51 60 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 104 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
208 
disease_progression 
H-positive risk:  697 677 103 1062 419 100 1072 415 161 61 183 50 
H-negative risk:  677 697 1072 1062 415 419 100 103 183 161 50 61 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 100 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
209 
disease_progression 
H-positive risk:  708 673 102 1062 422 102 1059 415 157 67 182 51 
H-negative risk:  673 708 1059 1062 415 422 102 102 182 157 51 67 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 102 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
210 
disease_progression 
H-positive risk:  696 674 101 1067 423 100 1069 415 155 67 182 51 
H-negative risk:  674 696 1069 1067 415 423 100 101 182 155 51 67 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 100 26 

clinical_engagement 
diagnosis 
demography 
63 new agents 
211 
disease_progression 
H-positive risk:  693 678 102 1077 416 95 1064 417 157 67 183 51 
H-negative risk:  678 693 1064 1077 417 416 95 102 183 157 51 67 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 102 27 

clinical_engagement 
diagnosis 
demography 
91 new agents 
212 
disease_progression 
H-positive risk:  693 681 103 1070 412 92 1069 421 159 64 185 51 
H-negative risk:  681 693 1069 1070 421 412 92 103 185 159 51 64 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 101 27 

clinical_engagement 
diagnosis 
demography 
70 new agents 
213 
disease_progression 
H-positive risk:  688 683 104 1077 409 89 1074 416 159 66 183 52 
H-negative risk:  683 688 1074 1077 416 409 89 104 183 159 52 66 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 104 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
214 
disease_progression 
H-positive risk:  691 679 106 1080 405 90 1075 415 160 64 180 55 
H-negative risk:  679 691 1075 1080 415 405 90 106 180 160 55 64 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 102 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
215 
disease_progression 
H-positive risk:  695 683 104 1068 410 90 1079 411 160 64 182 54 
H-negative risk:  683 695 1079 1068 411 410 90 104 182 160 54 64 
New BC onsets:  134
BC status:  4866 134 
BC subtype:  4866 107 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
216 
disease_progression 
H-positive risk:  689 682 105 1063 415 90 1085 415 158 65 182 51 
H-negative risk:  682 689 1085 1063 415 415 90 105 182 158 51 65 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 103 27 

clinical_engagement 
diagnosis 
demography 
62 new agents 
217 
disease_progression 
H-positive risk:  696 675 106 1063 413 93 1065 434 161 64 180 50 
H-negative risk:  675 696 1065 1063 434 413 93 106 180 161 50 64 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 102 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
218 
disease_progression 
H-positive risk:  683 673 106 1074 413 95 1078 424 162 63 178 51 
H-negative risk:  673 683 1078 1074 424 413 95 106 178 162 51 63 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 103 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
219 
disease_progression 
H-positive risk:  675 678 105 1082 412 97 1071 426 159 65 180 50 
H-negative risk:  678 675 1071 1082 426 412 97 105 180 159 50 65 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 100 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
220 
disease_progression 
H-positive risk:  683 681 104 1075 411 98 1062 433 162 61 183 47 
H-negative risk:  681 683 1062 1075 433 411 98 104 183 162 47 61 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 102 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
221 
disease_progression 
H-positive risk:  684 678 100 1068 411 99 1054 449 163 64 184 46 
H-negative risk:  678 684 1054 1068 449 411 99 100 184 163 46 64 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 103 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
222 
disease_progression 
H-positive risk:  686 677 100 1069 414 101 1057 446 159 60 183 48 
H-negative risk:  677 686 1057 1069 446 414 101 100 183 159 48 60 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 100 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
223 
disease_progression 
H-positive risk:  688 669 98 1076 411 102 1052 452 159 60 183 50 
H-negative risk:  669 688 1052 1076 452 411 102 98 183 159 50 60 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 98 28 

clinical_engagement 
diagnosis 
demography 
56 new agents 
224 
disease_progression 
H-positive risk:  685 667 100 1082 407 102 1048 458 158 61 182 50 
H-negative risk:  667 685 1048 1082 458 407 102 100 182 158 50 61 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 97 30 

clinical_engagement 
diagnosis 
demography 
88 new agents 
225 
disease_progression 
H-positive risk:  690 671 100 1087 406 102 1045 448 155 61 182 53 
H-negative risk:  671 690 1045 1087 448 406 102 100 182 155 53 61 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 99 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
226 
disease_progression 
H-positive risk:  693 656 99 1100 403 100 1038 457 154 64 183 53 
H-negative risk:  656 693 1038 1100 457 403 100 99 183 154 53 64 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 98 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
227 
disease_progression 
H-positive risk:  704 660 98 1093 404 98 1033 450 154 66 182 58 
H-negative risk:  660 704 1033 1093 450 404 98 98 182 154 58 66 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 99 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
228 
disease_progression 
H-positive risk:  709 665 98 1090 404 102 1038 440 158 65 178 53 
H-negative risk:  665 709 1038 1090 440 404 102 98 178 158 53 65 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 99 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
229 
disease_progression 
H-positive risk:  709 670 92 1082 416 99 1024 449 155 65 184 55 
H-negative risk:  670 709 1024 1082 449 416 99 92 184 155 55 65 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 101 22 

clinical_engagement 
diagnosis 
demography 
89 new agents 
230 
disease_progression 
H-positive risk:  705 672 94 1080 412 100 1032 449 149 71 183 53 
H-negative risk:  672 705 1032 1080 449 412 100 94 183 149 53 71 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 101 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
231 
disease_progression 
H-positive risk:  704 678 93 1075 411 101 1037 441 149 72 184 55 
H-negative risk:  678 704 1037 1075 441 411 101 93 184 149 55 72 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 101 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
232 
disease_progression 
H-positive risk:  710 679 97 1073 409 102 1039 436 143 74 183 55 
H-negative risk:  679 710 1039 1073 436 409 102 97 183 143 55 74 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 100 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
233 
disease_progression 
H-positive risk:  704 674 99 1081 406 102 1034 442 144 75 183 56 
H-negative risk:  674 704 1034 1081 442 406 102 99 183 144 56 75 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 99 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
234 
disease_progression 
H-positive risk:  700 677 97 1086 414 100 1036 431 143 76 182 58 
H-negative risk:  677 700 1036 1086 431 414 100 97 182 143 58 76 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 100 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
235 
disease_progression 
H-positive risk:  698 675 99 1093 411 102 1032 429 143 76 184 58 
H-negative risk:  675 698 1032 1093 429 411 102 99 184 143 58 76 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 104 22 

clinical_engagement 
diagnosis 
demography 
89 new agents 
236 
disease_progression 
H-positive risk:  697 673 98 1091 409 105 1033 439 142 73 184 56 
H-negative risk:  673 697 1033 1091 439 409 105 98 184 142 56 73 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 102 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
237 
disease_progression 
H-positive risk:  707 666 101 1099 403 105 1023 441 147 71 182 55 
H-negative risk:  666 707 1023 1099 441 403 105 101 182 147 55 71 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 106 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
238 
disease_progression 
H-positive risk:  708 663 102 1109 396 105 1024 440 144 71 185 53 
H-negative risk:  663 708 1024 1109 440 396 105 102 185 144 53 71 
New BC onsets:  130
BC status:  4870 130 
BC subtype:  4870 106 24 

clinical_engagement 
diagnosis 
demography 
93 new agents 
239 
disease_progression 
H-positive risk:  701 664 100 1103 394 102 1036 447 148 69 181 55 
H-negative risk:  664 701 1036 1103 447 394 102 100 181 148 55 69 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 105 22 

clinical_engagement 
diagnosis 
demography 
92 new agents 
240 
disease_progression 
H-positive risk:  702 664 101 1095 390 105 1035 453 146 70 183 56 
H-negative risk:  664 702 1035 1095 453 390 105 101 183 146 56 70 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 101 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
241 
disease_progression 
H-positive risk:  706 666 102 1086 393 105 1029 459 149 69 180 56 
H-negative risk:  666 706 1029 1086 459 393 105 102 180 149 56 69 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 100 22 

clinical_engagement 
diagnosis 
demography 
95 new agents 
242 
disease_progression 
H-positive risk:  705 668 106 1080 404 101 1027 454 154 68 176 57 
H-negative risk:  668 705 1027 1080 454 404 101 106 176 154 57 68 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 97 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
243 
disease_progression 
H-positive risk:  701 669 107 1080 405 101 1031 454 153 68 175 56 
H-negative risk:  669 701 1031 1080 454 405 101 107 175 153 56 68 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
244 
disease_progression 
H-positive risk:  699 667 107 1076 404 104 1038 457 148 68 176 56 
H-negative risk:  667 699 1038 1076 457 404 104 107 176 148 56 68 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 92 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
245 
disease_progression 
H-positive risk:  695 668 109 1072 403 105 1039 460 151 68 174 56 
H-negative risk:  668 695 1039 1072 460 403 105 109 174 151 56 68 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
246 
disease_progression 
H-positive risk:  707 671 111 1070 402 102 1045 447 151 64 172 58 
H-negative risk:  671 707 1045 1070 447 402 102 111 172 151 58 64 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
86 new agents 
247 
disease_progression 
H-positive risk:  704 671 107 1068 407 105 1050 438 152 63 175 60 
H-negative risk:  671 704 1050 1068 438 407 105 107 175 152 60 63 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
248 
disease_progression 
H-positive risk:  698 670 104 1057 417 104 1052 446 151 64 175 62 
H-negative risk:  670 698 1052 1057 446 417 104 104 175 151 62 64 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
249 
disease_progression 
H-positive risk:  698 671 106 1053 416 108 1055 439 149 64 179 62 
H-negative risk:  671 698 1055 1053 439 416 108 106 179 149 62 64 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
250 
disease_progression 
H-positive risk:  701 665 108 1055 408 109 1063 439 150 63 177 62 
H-negative risk:  665 701 1063 1055 439 408 109 108 177 150 62 63 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 83 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
251 
disease_progression 
H-positive risk:  691 667 109 1062 409 108 1067 436 148 64 178 61 
H-negative risk:  667 691 1067 1062 436 409 108 109 178 148 61 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
252 
disease_progression 
H-positive risk:  697 665 108 1066 400 108 1065 439 147 65 178 62 
H-negative risk:  665 697 1065 1066 439 400 108 108 178 147 62 65 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
253 
disease_progression 
H-positive risk:  694 662 109 1073 399 108 1072 436 146 64 174 63 
H-negative risk:  662 694 1072 1073 436 399 108 109 174 146 63 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
83 new agents 
254 
disease_progression 
H-positive risk:  690 666 110 1077 400 105 1081 424 146 65 174 62 
H-negative risk:  666 690 1081 1077 424 400 105 110 174 146 62 65 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
255 
disease_progression 
H-positive risk:  684 665 108 1076 407 105 1086 416 148 65 177 63 
H-negative risk:  665 684 1086 1076 416 407 105 108 177 148 63 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
59 new agents 
256 
disease_progression 
H-positive risk:  672 661 109 1079 416 109 1094 414 147 60 178 61 
H-negative risk:  661 672 1094 1079 414 416 109 109 178 147 61 60 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
257 
disease_progression 
H-positive risk:  677 662 108 1071 426 110 1093 414 145 60 176 58 
H-negative risk:  662 677 1093 1071 414 426 110 108 176 145 58 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
84 new agents 
258 
disease_progression 
H-positive risk:  676 653 106 1077 430 112 1098 410 144 60 178 56 
H-negative risk:  653 676 1098 1077 410 430 112 106 178 144 56 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 78 31 

clinical_engagement 
diagnosis 
demography 
81 new agents 
259 
disease_progression 
H-positive risk:  675 661 106 1077 420 113 1099 416 141 60 175 57 
H-negative risk:  661 675 1099 1077 416 420 113 106 175 141 57 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 75 29 

clinical_engagement 
diagnosis 
demography 
65 new agents 
260 
disease_progression 
H-positive risk:  679 659 105 1075 423 115 1094 416 144 56 175 59 
H-negative risk:  659 679 1094 1075 416 423 115 105 175 144 59 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 74 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
261 
disease_progression 
H-positive risk:  671 657 106 1077 428 114 1104 412 144 54 173 60 
H-negative risk:  657 671 1104 1077 412 428 114 106 173 144 60 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
73 new agents 
262 
disease_progression 
H-positive risk:  664 659 106 1071 428 112 1117 414 139 57 172 61 
H-negative risk:  659 664 1117 1071 414 428 112 106 172 139 61 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 79 29 

clinical_engagement 
diagnosis 
demography 
75 new agents 
263 
disease_progression 
H-positive risk:  664 664 105 1069 426 112 1125 409 141 54 172 59 
H-negative risk:  664 664 1125 1069 409 426 112 105 172 141 59 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 81 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
264 
disease_progression 
H-positive risk:  665 661 107 1068 426 105 1117 421 148 53 170 59 
H-negative risk:  661 665 1117 1068 421 426 105 107 170 148 59 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 84 28 

clinical_engagement 
diagnosis 
demography 
81 new agents 
265 
disease_progression 
H-positive risk:  671 659 104 1072 422 107 1120 421 148 51 167 58 
H-negative risk:  659 671 1120 1072 421 422 107 104 167 148 58 51 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 85 30 

clinical_engagement 
diagnosis 
demography 
89 new agents 
266 
disease_progression 
H-positive risk:  675 659 101 1080 418 105 1119 416 149 53 167 58 
H-negative risk:  659 675 1119 1080 416 418 105 101 167 149 58 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 83 29 

clinical_engagement 
diagnosis 
demography 
83 new agents 
267 
disease_progression 
H-positive risk:  678 660 101 1080 421 104 1114 419 148 50 163 62 
H-negative risk:  660 678 1114 1080 419 421 104 101 163 148 62 50 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
268 
disease_progression 
H-positive risk:  680 660 102 1075 427 102 1113 416 152 50 162 61 
H-negative risk:  660 680 1113 1075 416 427 102 102 162 152 61 50 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 80 28 

clinical_engagement 
diagnosis 
demography 
87 new agents 
269 
disease_progression 
H-positive risk:  680 657 101 1082 416 103 1124 413 150 48 162 64 
H-negative risk:  657 680 1124 1082 413 416 103 101 162 150 64 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 79 31 

clinical_engagement 
diagnosis 
demography 
86 new agents 
270 
disease_progression 
H-positive risk:  683 661 104 1086 405 101 1129 406 146 48 164 67 
H-negative risk:  661 683 1129 1086 406 405 101 104 164 146 67 48 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 81 31 

clinical_engagement 
diagnosis 
demography 
69 new agents 
271 
disease_progression 
H-positive risk:  688 651 101 1088 412 99 1127 409 148 49 163 65 
H-negative risk:  651 688 1127 1088 409 412 99 101 163 148 65 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 81 31 

clinical_engagement 
diagnosis 
demography 
64 new agents 
272 
disease_progression 
H-positive risk:  684 652 101 1088 415 97 1123 412 148 51 165 64 
H-negative risk:  652 684 1123 1088 412 415 97 101 165 148 64 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 79 30 

clinical_engagement 
diagnosis 
demography 
81 new agents 
273 
disease_progression 
H-positive risk:  684 647 103 1093 405 103 1125 410 148 49 169 64 
H-negative risk:  647 684 1125 1093 410 405 103 103 169 148 64 49 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 75 32 

clinical_engagement 
diagnosis 
demography 
74 new agents 
274 
disease_progression 
H-positive risk:  685 637 103 1099 405 104 1130 408 149 49 166 65 
H-negative risk:  637 685 1130 1099 408 405 104 103 166 149 65 49 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 76 33 

clinical_engagement 
diagnosis 
demography 
66 new agents 
275 
disease_progression 
H-positive risk:  679 630 105 1119 401 106 1134 403 148 47 165 63 
H-negative risk:  630 679 1134 1119 403 401 106 105 165 148 63 47 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 75 33 

clinical_engagement 
diagnosis 
demography 
84 new agents 
276 
disease_progression 
H-positive risk:  678 634 103 1128 397 104 1129 403 151 48 164 61 
H-negative risk:  634 678 1129 1128 403 397 104 103 164 151 61 48 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 78 31 

clinical_engagement 
diagnosis 
demography 
67 new agents 
277 
disease_progression 
H-positive risk:  679 639 103 1112 406 107 1117 412 149 50 161 65 
H-negative risk:  639 679 1117 1112 412 406 107 103 161 149 65 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
83 new agents 
278 
disease_progression 
H-positive risk:  690 642 102 1104 404 107 1124 412 142 50 160 63 
H-negative risk:  642 690 1124 1104 412 404 107 102 160 142 63 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
81 new agents 
279 
disease_progression 
H-positive risk:  690 636 104 1104 407 107 1124 407 140 53 162 66 
H-negative risk:  636 690 1124 1104 407 407 107 104 162 140 66 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
81 new agents 
280 
disease_progression 
H-positive risk:  687 638 101 1108 407 107 1131 400 138 54 159 70 
H-negative risk:  638 687 1131 1108 400 407 107 101 159 138 70 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
281 
disease_progression 
H-positive risk:  690 638 101 1098 407 109 1132 401 141 54 159 70 
H-negative risk:  638 690 1132 1098 401 407 109 101 159 141 70 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
282 
disease_progression 
H-positive risk:  685 627 102 1107 403 108 1135 398 146 55 165 69 
H-negative risk:  627 685 1135 1107 398 403 108 102 165 146 69 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 81 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
283 
disease_progression 
H-positive risk:  683 631 103 1113 403 111 1120 403 143 57 164 69 
H-negative risk:  631 683 1120 1113 403 403 111 103 164 143 69 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
284 
disease_progression 
H-positive risk:  676 631 102 1110 405 113 1129 398 141 57 166 72 
H-negative risk:  631 676 1129 1110 398 405 113 102 166 141 72 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
66 new agents 
285 
disease_progression 
H-positive risk:  669 635 104 1116 401 110 1133 397 142 57 164 72 
H-negative risk:  635 669 1133 1116 397 401 110 104 164 142 72 57 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
286 
disease_progression 
H-positive risk:  671 639 103 1111 401 108 1134 400 139 58 166 70 
H-negative risk:  639 671 1134 1111 400 401 108 103 166 139 70 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
287 
disease_progression 
H-positive risk:  675 625 102 1117 406 108 1133 405 135 56 168 70 
H-negative risk:  625 675 1133 1117 405 406 108 102 168 135 70 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
51 new agents 
288 
disease_progression 
H-positive risk:  666 622 105 1121 410 105 1132 410 139 57 164 69 
H-negative risk:  622 666 1132 1121 410 410 105 105 164 139 69 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
289 
disease_progression 
H-positive risk:  666 619 104 1135 404 103 1125 413 143 56 164 68 
H-negative risk:  619 666 1125 1135 413 404 103 104 164 143 68 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
290 
disease_progression 
H-positive risk:  657 617 102 1143 398 105 1130 415 144 57 164 68 
H-negative risk:  617 657 1130 1143 415 398 105 102 164 144 68 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
291 
disease_progression 
H-positive risk:  664 612 103 1146 397 105 1118 425 141 58 163 68 
H-negative risk:  612 664 1118 1146 425 397 105 103 163 141 68 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
93 new agents 
292 
disease_progression 
H-positive risk:  667 611 108 1143 403 105 1116 420 137 62 161 67 
H-negative risk:  611 667 1116 1143 420 403 105 108 161 137 67 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
293 
disease_progression 
H-positive risk:  664 611 104 1142 400 105 1132 410 138 61 165 68 
H-negative risk:  611 664 1132 1142 410 400 105 104 165 138 68 61 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
60 new agents 
294 
disease_progression 
H-positive risk:  658 599 102 1141 413 108 1133 411 139 60 166 70 
H-negative risk:  599 658 1133 1141 411 413 108 102 166 139 70 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
295 
disease_progression 
H-positive risk:  665 599 101 1135 421 106 1130 415 138 55 164 71 
H-negative risk:  599 665 1130 1135 415 421 106 101 164 138 71 55 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
296 
disease_progression 
H-positive risk:  675 599 103 1129 419 103 1123 422 138 54 162 73 
H-negative risk:  599 675 1123 1129 422 419 103 103 162 138 73 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
297 
disease_progression 
H-positive risk:  676 603 105 1138 411 102 1126 416 138 56 162 67 
H-negative risk:  603 676 1126 1138 416 411 102 105 162 138 67 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
298 
disease_progression 
H-positive risk:  677 616 106 1124 416 99 1131 403 142 56 164 66 
H-negative risk:  616 677 1131 1124 403 416 99 106 164 142 66 56 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
55 new agents 
299 
disease_progression 
H-positive risk:  672 620 107 1125 418 100 1130 406 142 56 164 60 
H-negative risk:  620 672 1130 1125 406 418 100 107 164 142 60 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
300 
disease_progression 
H-positive risk:  671 619 107 1128 413 101 1130 408 144 58 160 61 
H-negative risk:  619 671 1130 1128 408 413 101 107 160 144 61 58 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
301 
disease_progression 
H-positive risk:  676 618 107 1119 420 102 1130 407 140 61 152 68 
H-negative risk:  618 676 1130 1119 407 420 102 107 152 140 68 61 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
302 
disease_progression 
H-positive risk:  672 614 106 1131 419 102 1128 408 142 59 156 63 
H-negative risk:  614 672 1128 1131 408 419 102 106 156 142 63 59 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
99 new agents 
303 
disease_progression 
H-positive risk:  664 628 106 1121 415 105 1126 416 142 58 157 62 
H-negative risk:  628 664 1126 1121 416 415 105 106 157 142 62 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
304 
disease_progression 
H-positive risk:  668 627 107 1112 418 105 1127 417 141 57 159 62 
H-negative risk:  627 668 1127 1112 417 418 105 107 159 141 62 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
305 
disease_progression 
H-positive risk:  676 629 107 1107 425 101 1121 413 144 56 158 63 
H-negative risk:  629 676 1121 1107 413 425 101 107 158 144 63 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
306 
disease_progression 
H-positive risk:  672 630 108 1117 415 104 1124 416 143 57 156 58 
H-negative risk:  630 672 1124 1117 416 415 104 108 156 143 58 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
307 
disease_progression 
H-positive risk:  671 627 107 1120 419 104 1116 425 143 56 153 59 
H-negative risk:  627 671 1116 1120 425 419 104 107 153 143 59 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
308 
disease_progression 
H-positive risk:  677 632 105 1116 410 101 1130 420 143 54 153 59 
H-negative risk:  632 677 1130 1116 420 410 101 105 153 143 59 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
309 
disease_progression 
H-positive risk:  673 635 105 1120 404 103 1135 417 142 53 155 58 
H-negative risk:  635 673 1135 1120 417 404 103 105 155 142 58 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
310 
disease_progression 
H-positive risk:  674 631 105 1117 409 102 1137 420 145 52 150 58 
H-negative risk:  631 674 1137 1117 420 409 102 105 150 145 58 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
93 new agents 
311 
disease_progression 
H-positive risk:  682 639 106 1107 411 106 1126 415 147 52 153 56 
H-negative risk:  639 682 1126 1107 415 411 106 106 153 147 56 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 82 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
312 
disease_progression 
H-positive risk:  674 636 103 1120 402 105 1127 418 150 54 153 58 
H-negative risk:  636 674 1127 1120 418 402 105 103 153 150 58 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
313 
disease_progression 
H-positive risk:  679 636 102 1122 408 103 1110 421 153 54 153 59 
H-negative risk:  636 679 1110 1122 421 408 103 102 153 153 59 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
314 
disease_progression 
H-positive risk:  678 635 103 1126 409 100 1112 419 151 55 153 59 
H-negative risk:  635 678 1112 1126 419 409 100 103 153 151 59 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
315 
disease_progression 
H-positive risk:  682 642 100 1119 417 99 1109 412 156 54 152 58 
H-negative risk:  642 682 1109 1119 412 417 99 100 152 156 58 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
316 
disease_progression 
H-positive risk:  686 642 100 1122 411 96 1102 421 157 53 151 59 
H-negative risk:  642 686 1102 1122 421 411 96 100 151 157 59 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
317 
disease_progression 
H-positive risk:  679 646 96 1129 412 97 1098 425 156 52 150 60 
H-negative risk:  646 679 1098 1129 425 412 97 96 150 156 60 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
318 
disease_progression 
H-positive risk:  682 643 94 1130 408 100 1098 423 153 56 151 62 
H-negative risk:  643 682 1098 1130 423 408 100 94 151 153 62 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
319 
disease_progression 
H-positive risk:  686 639 93 1123 408 102 1096 428 152 56 152 65 
H-negative risk:  639 686 1096 1123 428 408 102 93 152 152 65 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
80 new agents 
320 
disease_progression 
H-positive risk:  689 651 92 1115 403 103 1093 426 155 57 153 63 
H-negative risk:  651 689 1093 1115 426 403 103 92 153 155 63 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
321 
disease_progression 
H-positive risk:  695 645 90 1119 402 102 1091 426 153 57 156 64 
H-negative risk:  645 695 1091 1119 426 402 102 90 156 153 64 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
322 
disease_progression 
H-positive risk:  693 645 92 1115 397 103 1102 424 157 55 151 66 
H-negative risk:  645 693 1102 1115 424 397 103 92 151 157 66 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
323 
disease_progression 
H-positive risk:  690 644 91 1114 403 100 1108 420 159 52 152 67 
H-negative risk:  644 690 1108 1114 420 403 100 91 152 159 67 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
324 
disease_progression 
H-positive risk:  693 645 91 1111 404 100 1098 420 164 51 155 68 
H-negative risk:  645 693 1098 1111 420 404 100 91 155 164 68 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
325 
disease_progression 
H-positive risk:  690 638 93 1115 402 99 1100 421 169 52 153 68 
H-negative risk:  638 690 1100 1115 421 402 99 93 153 169 68 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
326 
disease_progression 
H-positive risk:  685 638 93 1120 402 99 1106 426 164 53 148 66 
H-negative risk:  638 685 1106 1120 426 402 99 93 148 164 66 53 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
71 new agents 
327 
disease_progression 
H-positive risk:  687 645 92 1124 395 100 1105 429 159 53 147 64 
H-negative risk:  645 687 1105 1124 429 395 100 92 147 159 64 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
328 
disease_progression 
H-positive risk:  693 645 89 1114 395 101 1101 436 158 54 148 66 
H-negative risk:  645 693 1101 1114 436 395 101 89 148 158 66 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
329 
disease_progression 
H-positive risk:  688 640 90 1118 395 102 1105 439 157 51 149 66 
H-negative risk:  640 688 1105 1118 439 395 102 90 149 157 66 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
330 
disease_progression 
H-positive risk:  687 639 95 1109 404 107 1103 438 156 50 148 64 
H-negative risk:  639 687 1103 1109 438 404 107 95 148 156 64 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
331 
disease_progression 
H-positive risk:  687 643 95 1098 406 109 1098 442 158 48 149 67 
H-negative risk:  643 687 1098 1098 442 406 109 95 149 158 67 48 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
332 
disease_progression 
H-positive risk:  685 641 93 1100 405 109 1104 438 158 49 151 67 
H-negative risk:  641 685 1104 1100 438 405 109 93 151 158 67 49 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
333 
disease_progression 
H-positive risk:  687 638 88 1097 409 112 1104 436 154 53 154 68 
H-negative risk:  638 687 1104 1097 436 409 112 88 154 154 68 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
95 new agents 
334 
disease_progression 
H-positive risk:  689 639 90 1105 394 116 1109 433 158 48 154 65 
H-negative risk:  639 689 1109 1105 433 394 116 90 154 158 65 48 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
335 
disease_progression 
H-positive risk:  683 651 91 1098 396 116 1108 432 162 45 154 64 
H-negative risk:  651 683 1108 1098 432 396 116 91 154 162 64 45 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
83 new agents 
336 
disease_progression 
H-positive risk:  681 657 90 1099 395 118 1104 427 165 45 155 64 
H-negative risk:  657 681 1104 1099 427 395 118 90 155 165 64 45 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
337 
disease_progression 
H-positive risk:  684 662 95 1095 394 115 1102 428 163 46 156 60 
H-negative risk:  662 684 1102 1095 428 394 115 95 156 163 60 46 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
338 
disease_progression 
H-positive risk:  678 654 91 1106 395 114 1104 430 165 45 159 59 
H-negative risk:  654 678 1104 1106 430 395 114 91 159 165 59 45 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
339 
disease_progression 
H-positive risk:  680 644 91 1104 396 115 1107 430 165 49 159 60 
H-negative risk:  644 680 1107 1104 430 396 115 91 159 165 60 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
340 
disease_progression 
H-positive risk:  675 638 89 1112 399 115 1115 423 171 48 156 59 
H-negative risk:  638 675 1115 1112 423 399 115 89 156 171 59 48 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
89 new agents 
341 
disease_progression 
H-positive risk:  678 635 91 1106 407 112 1120 421 172 49 154 55 
H-negative risk:  635 678 1120 1106 421 407 112 91 154 172 55 49 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
342 
disease_progression 
H-positive risk:  679 646 89 1112 407 112 1106 425 169 46 157 52 
H-negative risk:  646 679 1106 1112 425 407 112 89 157 169 52 46 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
92 new agents 
343 
disease_progression 
H-positive risk:  677 647 88 1103 421 113 1099 432 167 45 159 49 
H-negative risk:  647 677 1099 1103 432 421 113 88 159 167 49 45 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
344 
disease_progression 
H-positive risk:  680 644 85 1115 419 113 1096 425 165 48 161 49 
H-negative risk:  644 680 1096 1115 425 419 113 85 161 165 49 48 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
345 
disease_progression 
H-positive risk:  682 647 87 1102 423 111 1092 432 168 46 158 52 
H-negative risk:  647 682 1092 1102 432 423 111 87 158 168 52 46 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
346 
disease_progression 
H-positive risk:  679 649 86 1104 424 111 1099 430 159 48 159 52 
H-negative risk:  649 679 1099 1104 430 424 111 86 159 159 52 48 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
347 
disease_progression 
H-positive risk:  680 649 87 1100 421 107 1102 431 164 46 159 54 
H-negative risk:  649 680 1102 1100 431 421 107 87 159 164 54 46 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
348 
disease_progression 
H-positive risk:  675 652 85 1100 423 106 1099 437 162 48 158 55 
H-negative risk:  652 675 1099 1100 437 423 106 85 158 162 55 48 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
349 
disease_progression 
H-positive risk:  673 658 84 1096 422 106 1104 430 164 48 162 53 
H-negative risk:  658 673 1104 1096 430 422 106 84 162 164 53 48 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
350 
disease_progression 
H-positive risk:  665 664 84 1102 423 109 1105 428 162 47 159 52 
H-negative risk:  664 665 1105 1102 428 423 109 84 159 162 52 47 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
351 
disease_progression 
H-positive risk:  669 662 85 1105 430 112 1095 422 164 46 159 51 
H-negative risk:  662 669 1095 1105 422 430 112 85 159 164 51 46 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
85 new agents 
352 
disease_progression 
H-positive risk:  675 660 87 1090 430 113 1092 431 161 49 157 55 
H-negative risk:  660 675 1092 1090 431 430 113 87 157 161 55 49 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
353 
disease_progression 
H-positive risk:  667 658 86 1099 426 113 1095 433 158 50 157 58 
H-negative risk:  658 667 1095 1099 433 426 113 86 157 158 58 50 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 83 27 

clinical_engagement 
diagnosis 
demography 
90 new agents 
354 
disease_progression 
H-positive risk:  660 666 88 1104 428 110 1099 424 157 51 157 56 
H-negative risk:  666 660 1099 1104 424 428 110 88 157 157 56 51 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 82 28 

clinical_engagement 
diagnosis 
demography 
74 new agents 
355 
disease_progression 
H-positive risk:  657 668 92 1101 429 111 1105 424 154 50 155 54 
H-negative risk:  668 657 1105 1101 424 429 111 92 155 154 54 50 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 86 28 

clinical_engagement 
diagnosis 
demography 
81 new agents 
356 
disease_progression 
H-positive risk:  661 669 92 1109 425 106 1102 417 161 50 157 51 
H-negative risk:  669 661 1102 1109 417 425 106 92 157 161 51 50 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 86 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
357 
disease_progression 
H-positive risk:  659 667 89 1112 421 107 1105 415 161 50 161 53 
H-negative risk:  667 659 1105 1112 415 421 107 89 161 161 53 50 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
358 
disease_progression 
H-positive risk:  663 671 91 1117 421 105 1092 418 159 47 162 54 
H-negative risk:  671 663 1092 1117 418 421 105 91 162 159 54 47 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
359 
disease_progression 
H-positive risk:  662 674 91 1113 416 106 1092 420 161 50 161 54 
H-negative risk:  674 662 1092 1113 420 416 106 91 161 161 54 50 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
360 
disease_progression 
H-positive risk:  670 675 96 1113 419 102 1083 416 160 53 159 54 
H-negative risk:  675 670 1083 1113 416 419 102 96 159 160 54 53 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
68 new agents 
Time difference of 18.31338 mins
This is task 8
date
